ATP5PDP1

Across TCGA pan-cancer cohorts, ATP5PDP1 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated ATP5PDP1 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher ATP5PDP1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ATP5PDP1 expression acts as an unfavorable survival marker, although some lineages such as CESC and STAD show a favorable association.

KICH, UVM, and CESC are the cancer types where ATP5PDP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	OS	Tertile	All	0.548	0.930	<.001	107	view →
UVM	DFS	Tertile	III,IV	0.283	0.652	.001	86	view →
CESC	DFS	Tertile	All	0.697	0.460	.001	74	view →
SKCM	OS	Tertile	IV	0.239	0.668	.004	23	view →
READ	OS	Quartile	IV	0.441	0.935	.001	21	view →
STAD	DFS	Median	IV	0.503	0.134	.001	12	view →
OV	DFS	Median	IV	0.535	0.357	.019	12	view →
THCA	OS	Tertile	II,III,IV	1.000	0.924	.012	11	view →
PCPG	DFS	Tertile	All	1.000	0.737	.022	8	view →
MESO	DFS	Tertile	IV	0.184	0.444	.041	6	view →
HNSC	OS	Tertile	IV	0.822	0.689	.023	4	view →
ESCA	OS	Median	All	1.000	0.534	.020	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

ATP5PDP1–KICH (OS)

Open the KICH breakdown →